Equities
Health CarePharmaceuticals & Biotechnology
  • Price (USD)86.03
  • Today's Change0.44 / 0.51%
  • Shares traded2.47m
  • 1 Year change-28.42%
  • Beta0.6178
Data delayed at least 15 minutes, as of Feb 16 2018 21:00 GMT.
More ▼

Key statistics

On Friday, Incyte Corp (INCY:NSQ) closed at 86.03, 6.41% above its 52-week low of 80.85, set on Feb 09, 2018.
52-week range
Today
80.85Feb 09 2018153.15Mar 15 2017
Markit short selling activity
Low
Med
High
Open85.55
High88.23
Low84.51
Bid85.66
Offer88.80
Previous close85.59
Average volume2.11m
Shares outstanding211.04m
Free float208.31m
P/E (TTM)--
Market cap18.16bn USD
EPS (TTM)-1.56
USD
Data delayed at least 15 minutes, as of Feb 16 2018 21:00 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.